Curetrix Export

Metformin is an anti-diabetic medication (biguanide). It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body’s sensitivity to insulin. Vildagliptin is a DPP-4 inhibitor which works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces both fasting and postmeal sugar levels. Together, they provide better control of blood sugar.

Vildagliptin/Metformin hydrochloride Accord is a diabetes medicine that is used in addition to diet and exercise to improve control of blood glucose (sugar) levels in adults with type 2 diabetes.

Pioglitazone + Vildagliptin is a combination of two antidiabetic medications. Pioglitazone primarily acts on muscle, fat, and liver cells to enhance their response to insulin, making it easier for these cells to take up glucose from the bloodstream. It also reduces the production of glucose by the liver, which is a common problem in people with type 2 diabetes. Vildagliptin helps increase insulin secretion in response to meals while suppressing the release of glucagon, a hormone that raises blood sugar levels. Therefore, these tablets decrease blood glucose levels

Vildagliptin is an antidiabetic medication. It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces the fasting and postmeal sugar levels.

Vildagliptin is an antidiabetic medication. It works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces the fasting and postmeal sugar levels.

Dapagliflozin + Vildagliptin is a combination of two antidiabetic medications. Dapagliflozin increases urinary glucose excretion and reduces blood glucose levels. Vildagliptin reduces the amount of glucose produced by the liver, by raising insulin levels and decreasing the levels of the glucagon (the hormone that increases blood glucose level).